Health authorities in England are launching a vaccination campaign to protect young people against meningitis B, a potentially life-threatening bacterial infection. The initiative comes in response to an outbreak that occurred in Kent in March, which resulted in 29 confirmed or suspected cases and two deaths, described by officials as unprecedented and explosive in its rapid spread.
Approximately one million young people are eligible for the free vaccine under the new campaign. The primary target groups include individuals born between 1 September 2007 and 31 August 2008, as well as students born on or after 21 July 2001 who are entering university or residential further education colleges for the first time this autumn. International students and those from other parts of the UK studying in England are also eligible. Nearly 90,000 doses have already been administered, with an additional 135,000 appointments scheduled for upcoming weeks.
The vaccine is administered in two doses, with at least 28 days required between doses, and both are necessary for optimal protection. Seventeen and 18-year-olds can book appointments through the NHS National Booking Service if registered with a general practitioner, while other eligible individuals can access walk-in services at participating high street pharmacies without requiring GP registration. Around 10,000 residents in the Kent region had already received vaccinations as part of the initial outbreak response.
Meningitis B can cause severe complications including inflammation of the brain lining and blood poisoning, potentially leading to life-altering disabilities such as hearing loss, amputation, or brain damage, and can be fatal in some cases. Research indicates that first-year university students face approximately seven times higher risk than their non-university-attending peers. The infection spreads through close contact, which health officials note is heightened in university dormitories and shared accommodation settings.
The vaccine, which contains no live bacteria and therefore cannot cause meningitis, was added to routine childhood immunizations for babies born on or after 1 July 2015. However, teenagers and young adults aged 11 and older have not received routine vaccination. Vaccine experts have recommended that government officials consider routinely offering the vaccine to all teenagers around age 15, though such decisions remain with individual UK nations. Common side effects include injection site reactions and mild symptoms like fever or muscle aches, typically resolving within one to two days, with serious adverse effects being rare.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI